chr6-31138746-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_014068.3(PSORS1C1):c.134G>T(p.Arg45Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R45Q) has been classified as Benign.
Frequency
Consequence
NM_014068.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSORS1C1 | NM_014068.3 | c.134G>T | p.Arg45Leu | missense_variant | 5/6 | ENST00000259881.10 | |
PSORS1C2 | NM_014069.3 | c.55+226C>A | intron_variant | ENST00000259845.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSORS1C1 | ENST00000259881.10 | c.134G>T | p.Arg45Leu | missense_variant | 5/6 | 1 | NM_014068.3 | P2 | |
PSORS1C2 | ENST00000259845.5 | c.55+226C>A | intron_variant | 1 | NM_014069.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000562 AC: 14AN: 249046Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135022
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461858Hom.: 0 Cov.: 37 AF XY: 0.0000289 AC XY: 21AN XY: 727236
GnomAD4 genome AF: 0.000158 AC: 24AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74366
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at